Heartflow (NASDAQ:HTFL) Price Target Raised to $40.00

Heartflow (NASDAQ:HTFL) had its target price upped by Stifel Nicolaus from $35.00 to $40.00 in a report issued on Thursday morning,Benzinga reports. Stifel Nicolaus currently has a buy rating on the stock.

Several other analysts have also recently weighed in on the stock. Zacks Research upgraded shares of Heartflow to a “hold” rating in a report on Wednesday, September 3rd. Canaccord Genuity Group raised their price objective on Heartflow from $35.00 to $39.00 and gave the company a “buy” rating in a research report on Monday, September 22nd. JPMorgan Chase & Co. initiated coverage on shares of Heartflow in a report on Tuesday, September 2nd. They issued an “overweight” rating and a $36.00 target price for the company. Weiss Ratings assumed coverage on Heartflow in a report on Saturday, November 1st. They set a “sell (d+)” rating on the stock. Finally, Morgan Stanley assumed coverage on shares of Heartflow in a report on Tuesday, September 2nd. They issued an “equal weight” rating and a $35.00 target price on the stock. Four research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $38.60.

Heartflow Price Performance

NASDAQ HTFL opened at $27.98 on Thursday. Heartflow has a 1-year low of $26.56 and a 1-year high of $41.22. The firm has a 50-day moving average of $34.60.

Heartflow (NASDAQ:HTFL) last issued its earnings results on Friday, September 19th. The company reported ($1.46) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($1.26). The firm had revenue of $43.42 million for the quarter, compared to analysts’ expectations of $43.20 million.

Hedge Funds Weigh In On Heartflow

Several hedge funds have recently modified their holdings of HTFL. Atika Capital Management LLC bought a new stake in shares of Heartflow in the third quarter worth about $2,323,000. JPMorgan Chase & Co. bought a new stake in Heartflow in the third quarter worth $13,887,000. TD Asset Management Inc purchased a new position in shares of Heartflow during the 3rd quarter worth about $2,692,000. Legato Capital Management LLC purchased a new position in shares of Heartflow during the third quarter valued at approximately $243,000. Finally, Artisan Partners Limited Partnership bought a new position in Heartflow in the 3rd quarter valued at $16,817,000.

About Heartflow

We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.